Wenyuan Qian

This inventor holds 23 USPTO granted patents and 7 published patent applications, plus 11 CIPO patents and 17 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Medshine Discovery Inc., Wuxi Biocity Biopharmaceutics Co., Ltd., Kpc Pharmaceuticals, Inc.. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wenyuan Qian. Retrieved from https://idiyas.com/inventor/wenyuan-qian-btxponqs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 23 (Patent Applications = 7)

% Patents Active = 95.7

CIPO Patents = 11 (Patent Applications = 11)

EPO Patents = 17 (Patent Applications = 33)

Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 4(Granted Patents)

Company Filing History:

8 out of 72

Medshine Discovery Inc.

patents

5 out of 5

Wuxi Biocity Biopharmaceutics Co., Ltd.

patents

2 out of 5

Kpc Pharmaceuticals, Inc.

patents

4. 2 out of 2

Ocumension Therapeutics (Suzhou) Co., Ltd.

patents

5. 2 out of 8

Zhuhai United Laboratories Co., Ltd.

patents

6. 1 out of 12

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

patents

7. 1 out of 7

Cisen Pharmaceutical Co., Ltd.

patents

8. 1 out of 9

Cstone Pharmaceuticals

patents

9. 1 out of 7

Cstone Pharmaceuticals (Shanghai) Co., Ltd.

patents

10. 1 out of 5

Cstone Pharmaceuticals (Suzhou) Co., Ltd.

patents

11. 1 out of 4

Guangzhou Joyo Pharmatech Co., Ltd.

patents

12. 1 out of 1

Jumbo Drug Bank Co., Ltd.

patent

13. 1 out of 5

Shijiazhuang Sagacity New Drug Development Company, Ltd.

patents

where one patent can have more than one assignee

Years Active: 2019-2026

Loading Chart...

Areas of Expertise:

Bifunctional Compound

JAK Inhibitor

Wee1 Inhibitor

Pyrazole Derivative

Pyrrolopyrimidine

HDAC6 Inhibitor

CSF-1R Inhibitor

Divalent IAP Antagonist

Crystalline Form

Salt Form

Macrocyclic Compound

Substituted Thiadiazoles

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12655135 - Benzo seven-membered ring bifunctional compound and application thereof (2026-06-16),

2. 12649747 - Salt form and crystal form of pyrazole substituted imidazo[1,2-a]quinoxaline derivative (2026-06-09),

3. 12637469 - 1H-pyrazole derivative and application thereof as dual target inhibitor of Syk and VEGFR2 (2026-05-26),

4. 12552789 - 1H-pyrrolo[2,3-c]pyridine compounds and application thereof (2026-02-17),

5. 12486266 - Crystalline form of JAK inhibitor and application thereof (2025-12-02),

6. 12479839 - Crystalline form of ATR inhibitor and use thereof (2025-11-25),

7. 12428391 - Dimethylsulfoximine derivative (2025-09-30),

8. 12391653 - Salt form and crystal form of mutant IDH1 inhibitor and preparation method therefor (2025-08-19),

9. 12351590 - Pyrrolopyrimidine compound and use thereof (2025-07-08),

10. 12291536 - Crystal form of Wee1 inhibitor compound and use thereof (2025-05-06),

11. 12180184 - Pyrimidopyrazolone derivative as Wee1 inhibitor and use thereof (2024-12-31),

12. 11919896 - [1,2,4]triazolo[1,5-a]pyridine compound as JAK inhibitor and use thereof (2024-03-05),

13. 11634424 - Diazaindole derivative and use thereof as CHK1 inhibitor (2023-04-25),

14. 11613545 - Macrocyclic compound serving as Wee1 inhibitor and applications thereof (2023-03-28),

15. 11434232 - ATR inhibitor and application thereof (2022-09-06),

Title: Inventor Wenyuan Qian

Introduction: Wenyuan Qian is a renowned inventor based in Shanghai, China, known for his groundbreaking contributions to various technological fields.

Latest Patents: Wenyuan Qian holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: With a career spanning over two decades, Wenyuan Qian has worked with leading research institutions and multinational companies, consistently pushing the boundaries of innovation and technology.

Collaborations: Throughout his career, Wenyuan Qian has collaborated with top scientists, engineers, and researchers from around the world, fostering a culture of creativity and excellence in his projects.

Conclusion: Wenyuan Qian's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and researchers worldwide.

Profile summary based on public USPTO records.